In adults with obesity, metabolic–bariatric surgery vs. usual care is associated with lower all-cause mortality

cover

References

  • 1 Sheng B, Truong K, Spitler H, et al. The long-term effects of bariatric surgery on type 2 diabetes remission, microvascular and macrovascular complications, and mortality: a systematic review and meta-analysis. Obes Surg. 2017;27:2724–32. [PMID: 28801703] Google Scholar
  • 2 Zenténius E, Andersson-Assarsson JC, Carlsson LM, et al. Self-reported weight-loss methods and weight change: ten-year analysis in the Swedish Obese Subjects study control group. Obesity (Silver Spring). 2018;26:1137-43. [PMID: 29873894] Google Scholar
  • 3 Pontiroli AE, Zakaria AS, Fanchini M, et al. A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity. Cardiovasc Diabetol. 2018;17:161. [PMID: 30594184] Google Scholar
  • 4 Wadden TA, Bailey TS, Billings LK, et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021;325:1403-13. [PMID: 33625476] Google Scholar
  • 5 Gasoyan H, Tajeu G, Halpern MT, et al. Reasons for underutilization of bariatric surgery: the role of insurance benefit design. Surg Obes Relat Dis. 2019;15:146-51. [PMID: 30425002] Google Scholar

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *